Hi there,

In the six months since President Trump’s inauguration, we have seen unprecedented attacks on the press. Instead of pushing back, corporate owners of commercial networks are caving in. Because we do not accept any corporate or government funding, we rely on audience members like you to sustain our work. I hope you will donate today to support our independent journalism.Thanks to a group of generous donors, all donations today will be TRIPLED, which means your $15 gift is worth $45. If you believe that freedom of speech and freedom of the press are essential to the functioning of a democratic society, please donate today. Every dollar makes a difference. Thank you so much.

Democracy Now!
Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

J&J Vaccine Trials Show Promise as CDC Predicts 92,000 More U.S. Deaths in Next 3 Weeks

HeadlineJan 14, 2021

Ninety-two thousand more people in the U.S. could die of COVID-19 in the next three weeks, according to a grim forecast issued by the Centers for Disease Control and Prevention. Another 3,800 deaths were reported Wednesday, and over 225,000 new confirmed cases. Over 130,000 people are hospitalized with COVID-19.

Pennsylvania said its number of hospitalizations is now close to double the peak of the spring’s first wave. Arizona officials also reported record-high hospitalization and ICU numbers this week. A staggering one in three Los Angeles County residents has gotten the coronavirus since the start of the pandemic, according to new data.

Early trials for Johnson & Johnson’s experimental coronavirus vaccine are showing promising results. If further trials prove effective, the vaccine could be a game-changer as it requires just one shot and does not need to be stored in ultra-cold freezers.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top